Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodula
Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodulation
What it found
We found no results in the registry or in papers.
This trial finished 15 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Portable Neuromodulation Stimulator
What it measured
Main measures
Dynamic Gait Index DGI
14 weeks
Walking and mobilityHow the body handles the medicine
Who could take part
Relapsing and progressive · 18 to 65
Show the full criteria
Inclusion criteria
All subjects are initially evaluated for inclusion/exclusion on the Kurtzke Expanded Disability Status Scale (EDSS), a test typically administered by their healthcare provider as an ongoing part of standard therapy for M.S Inclusion Criteria: * Relapsing remitting MS ("RRMS"), primary progressive MS ("PPMS"), or secondary progressive MS ("SPMS") without relapse within 6 months of enrollment; * EDSS score of 3.0 - 6.0 ; * No changes in medication within 3 months of enrollment; * Ability to walk 20 minutes on a treadmill (with handrail support as needed) without rest; * Provided informed consent and willing to participate.
Exclusion criteria
• Major co-morbidities, especially other neurological disorders, uncontrolled pain, hypertension, diabetes, or oral health problems
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study sought to examine the effect of targeted physical therapy with and without cranial nerve non-invasive neuromodulation (CN-NINM), on the walking ability of people with MS who exhibited a dysfunctional gait.
Papers
Loading reviews and guidelines…
History
Started
Nov 2009
Main results due
May 2011
Finished
May 2011